SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Idera Pharmaceuticals, Inc.
(NASDAQ : IDRA)

( )
IDRA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading IDRA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.35%78.971.1%$778.95m
SRPTSarepta Therapeutics, Inc.
5.31%62.2427.0%$475.37m
AMGNAmgen Inc.
-1.12%169.711.2%$462.12m
BIIBBiogen Inc.
-1.27%310.551.1%$427.51m
MDVNMedivation, Inc.
0.05%81.481.9%$393.20m
CELGCelgene Corporation
-1.46%105.830.9%$388.18m
REGNRegeneron Pharmaceuticals, Inc.
-0.56%419.103.7%$315.62m
CPHDCepheid
0.11%52.695.5%$214.32m
ALXNAlexion Pharmaceuticals, Inc.
-1.76%123.762.2%$173.50m
CLVSClovis Oncology, Inc.
-2.94%36.3428.4%$163.46m
ILMNIllumina, Inc.
0.35%180.983.4%$139.93m
VRTXVertex Pharmaceuticals Incorporated
-0.31%88.842.3%$127.85m
INCYIncyte Corporation
4.64%93.202.8%$120.53m
BMRNBioMarin Pharmaceutical Inc.
-1.05%96.034.0%$114.07m
TSROTESARO, Inc.
-3.35%104.4217.5%$109.74m

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera's immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while its third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.